Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Equity

v3.20.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Share capital
Share premium
Capital reserve from share-based payment transactions
Warrants exercisable into shares
Treasury shares
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Non-controlling interests
Total
Balance at Dec. 31, 2016 $ 1,783 $ 79,864 $ 5,167 $ 6,947 $ (970) $ 491 $ (87,363) $ 5,919 $ 42 $ 5,961
Net loss (6,339) (6,339) (94) (6,433)
Adjustment arising from translating financial statements from functional currency to presentation currency 636 636 636
Total comprehensive loss 636 (6,339) (5,703) (94) (5,797)
Issuance of share capital and warrants, net of issue expenses 330 1,993 188 1,868 4,379 4,379
Issuance of share capital 10 85 95 95
Proceeds from sale of subsidiary in previously consolidated subsidiaries (838) 970 132 52 184
Share-based payments 192 192 192
Balance at Dec. 31, 2017 2,123 81,104 5,547 8,815 1,127 (93,702) 5,014 5,014
Net loss (6,571) (6,571) (6,571)
Total comprehensive loss                   (6,571)
Cumulative effect of initial adoption of IFRS 15 as of January 1, 2018 (see Note 4) (350) (350) (350)
Issuance of share capital and warrants, net of issue expenses 482 312 3,593 4,387 4,387
Issuance of share capital 30 252 282 282
Share-based payments 253 253 253
Balance at Dec. 31, 2018 2,635 94,076 [1] 5,800 [1] 1,127 (100,623) $ 3,287 3,015
Net loss             (9,587)     (9,587)
Total comprehensive loss                   (9,587)
Issuance of share capital and warrants, net of issue expenses 5,518 1,546               7,064
Issuance of share capital 72 43               115
Share-based payments     270             270
Balance at Dec. 31, 2019 $ 8,225 $ 95,665 $ 6,070     $ 1,127 $ (110,210)     $ 877
[1] Warrants exercisable into shares as of December 31, 2018 were reclassified into Share premium.